Traditional fertility benefit practices — like dollar cap benefits and step therapy — are creating inequities in treatment, said Ann Gaines, senior vice president of business development at Progyny. Gaines made these comments Wednesday during the Midwest Business Group on Health conference in Chicago.
Don't miss this upcoming webinar on May 19th! The panelists will focus on how health systems are taking lessons learned from online retailers, and emerging technologies, to attract and convert consumers.
INVEST 2023 in Chicago May 22-24 is your opportunity to meet and connect with these investors: Insight Partners and Arboretum Ventures, plus innovative startups, additional investors and life sciences companies. Don't miss healthcare's greatest networking event of the year.
A drug developed by Protalix BioTherapeutics and Chiesi Group is now FDA approved for treating Fabry disease, a rare inherited metabolic disorder. The drug, Elfabrio, is an enzyme replacement therapy.
Medical Affairs plays a critical role when it comes to driving adherence to evidence-based medicine (EBM) – the principle that clinical decisions should be informed by the best available scientific evidence, along with clinical experience and patient preference.
Regulators have become increasingly concerned about the potential for medical devices to become a vector for spreading malware attacks across hospital networks, resulting in untold patient harm and billions of dollars globally.
This one-page checklist quickly shows you everything that is required for you to become HIPAA compliant. Make sure you aren't missing a thing when it comes to your organization's compliance.
No comments